HUP2100259A1 - Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények - Google Patents

Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények

Info

Publication number
HUP2100259A1
HUP2100259A1 HU2100259A HUP2100259A HUP2100259A1 HU P2100259 A1 HUP2100259 A1 HU P2100259A1 HU 2100259 A HU2100259 A HU 2100259A HU P2100259 A HUP2100259 A HU P2100259A HU P2100259 A1 HUP2100259 A1 HU P2100259A1
Authority
HU
Hungary
Prior art keywords
cariprazine
formulation
controlled release
release injectable
injectable
Prior art date
Application number
HU2100259A
Other languages
English (en)
Inventor
Konta Melinda Dr
Lazar Jozsef Dr
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU2100259A priority Critical patent/HUP2100259A1/hu
Priority to PCT/IB2022/056227 priority patent/WO2023281404A1/en
Publication of HUP2100259A1 publication Critical patent/HUP2100259A1/hu

Links

HU2100259A 2021-07-07 2021-07-07 Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények HUP2100259A1 (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU2100259A HUP2100259A1 (hu) 2021-07-07 2021-07-07 Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények
PCT/IB2022/056227 WO2023281404A1 (en) 2021-07-07 2022-07-06 Controlled release injectable cariprazine formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2100259A HUP2100259A1 (hu) 2021-07-07 2021-07-07 Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények

Publications (1)

Publication Number Publication Date
HUP2100259A1 true HUP2100259A1 (hu) 2023-01-28

Family

ID=89577952

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2100259A HUP2100259A1 (hu) 2021-07-07 2021-07-07 Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények

Country Status (2)

Country Link
HU (1) HUP2100259A1 (hu)
WO (1) WO2023281404A1 (hu)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS568318A (en) 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
ES2236700T3 (es) 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
TW487572B (en) 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
CZ300725B6 (cs) 1997-09-30 2009-07-29 Eli Lilly And Company 2-Methylthienbenzodiazepinová formulace
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
UA80095C2 (en) 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
HU227534B1 (en) 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
PL1675573T4 (pl) 2003-10-23 2016-04-29 Otsuka Pharma Co Ltd Sterylny preparat do wstrzykiwań arypiprazolu o kontrolowanym uwalnianiu i sposób
US20170196802A1 (en) 2016-01-08 2017-07-13 Abon Pharmaceuticals, Llc Long Acting Injectable Formulations
CN108261394B (zh) 2017-01-04 2022-03-04 广东东阳光药业有限公司 一种盐酸卡利拉嗪注射制剂及其制备方法和用途
US11344503B2 (en) * 2019-12-13 2022-05-31 Halo Science LLC Cariprazine release formulations

Also Published As

Publication number Publication date
WO2023281404A1 (en) 2023-01-12

Similar Documents

Publication Publication Date Title
EP3452003A4 (en) PHARMACEUTICAL FORM WITH CONTROLLED RELEASE
EP3890732A4 (en) INJECTABLE FORMULATIONS
IL268275A (en) An injectable composition for preventing hair loss or encouraging hair growth
ZA201905308B (en) Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth
ZA202001261B (en) Accelerating admixture for hydraulic compositions
IL275206A (en) Dry implant composition and aqueous injection formulation of the implant
GB201802339D0 (en) Immunogenic composition
IL270273B1 (en) Highly charged drug formulations with enhanced sustained release
IL284688A (en) formulation
IL282753A (en) Immunogenic compounds
SG11202004525TA (en) Pharmaceutical compositions having a selected release duration
HUP2100259A1 (hu) Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények
EP3902526A4 (en) INJECTABLE DELAYED RELEASE NALTREXONE FORMULATION
IL277802A (en) compound for injection
EP3216452A4 (en) Composition for preventing or treating mucositis comprising necrox as effective ingredient
GB201913232D0 (en) Aerosolisable formulation
EP3858377A4 (en) INJECTABLE COMPOSITION
GB202013571D0 (en) Injectable formulation
GB201803692D0 (en) Immunogenic composition
EP4037664A4 (en) ODANSETRON INJECTABLE CONTROLLED RELEASE FORMULATIONS
GB202113944D0 (en) Injectable formulations
ZA202102140B (en) Sustained-release injectable antibiotical formulation
IL287762A (en) Controlled-release lipid preparations
GB2587402B (en) Formulation
ZA202105883B (en) Ready-to-use injectable formulations